Assessing the Impact of NYC’s Test & Trace Program
A report from researchers at NYU Langone identifies the strengths and challenges of New York City’s contact tracing program for COVID-19.
Asthma Research Yields New Treatment for Enzyme Disease
NYU Langone study suggests a possible new way to treat Gaucher’s disease, a rare disease marked by the inability of cells to break down fats.
At-Birth Surgery Saves Baby with Rare Disorder
A multispecialty team at Hassenfeld Children’s Hospital at NYU Langone performed a complex at-birth procedure to save a baby with rare disorder.
At High Risk for Cancer, This Patient Embraced Prevention
Genetic testing and counseling from NYU Langone helped Rachel understand her familial risk for breast and ovarian cancer—and how to head it off.
At-Home Cognitive Remediation May Ease MS Symptoms
Cognitive changes are a troubling symptom of multiple sclerosis, but new NYU Langone research suggests cognitive remediation at home may help.
At Last: A Permanent Fix for Repeated Atrial Fibrillation
Medication had controlled Catherine’s A-fib symptoms, but only temporarily; NYU Langone’s Heart Rhythm Center found her a permanent solution.
At Perlmutter Cancer Center, Quality of Life Is a Priority
Dr. Abraham Chachoua, an oncologist at NYU Langone’s Perlmutter Cancer Center, aims to help patients live with a high a quality of life.
at-time-of-death-card.pdf
At the Time of Death Call: 212-263-6262 Monday-Friday, 9am-5pm 347-949-1424 24 Hours Please leave a message ...
Atezolizumab Receives FDA Approval to Treat Bladder Cancer
Clinical research led by NYU Langone’s Arjun Balar, MD, helped secure FDA approval for atezolizumab as a treatment for bladder cancer.
Athletes’ Injuries May Mean Better Healthcare for You
Spine surgeon Dr. Charla R. Fischer explains to MD Magazine how advances in sports medicine impact primary care.